A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the long-term safety, tolerability, and efficacy
of MP-214 in patients with receiving multiple drugs schizophrenia.